Announcement on Obtaining Drug Registration Certificate by the Wholly-owned Subsidiary
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Filed with SSE · · 2 pages · Chinese
HeiLongJiang ZBD Pharmaceutical Co., Ltd. announced that its wholly-owned subsidiary has obtained a drug registration certificate for a specific antibiotic product. The drug, moxifloxacin hydrochloride tablets, is approved for production and sale in the domestic market, enhancing the company's product offerings in the anti-infection sector. The company has invested significantly in the research and development of this drug, which is expected to improve its competitive position in the market. However, the company cautions that production and sales are subject to regulatory and market uncertainties.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
On 6ix: 6ix.com/news/announcement-on-obtaining-drug-registration-certificate-by-the-wholly-owned-subsidiary
Announcement on Obtaining Drug Registration Certificate by the Wholly-owned Subsidiary
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
HeiLongJiang ZBD Pharmaceutical Co., Ltd. on 6ix
Follow HeiLongJiang ZBD Pharmaceutical into a list and get an email when it puts out news.
Follow HeiLongJiang ZBD Pharmaceutical